|
ACMR
ACM Research, Inc.
ACMR · Q2 FY2020
|
Q2 FY2020 |
|
ACMR Q2 FY2020 transcript
|
|
GFL
GFL Environmental Inc.
GFL · Q2 FY2020
|
Q2 FY2020 |
|
GFL Q2 FY2020 transcript
|
|
DCBO
Docebo Inc.
DCBO · Q2 FY2020
|
Q2 FY2020 |
|
DCBO Q2 FY2020 transcript
|
|
MBI
Mbia Inc
MBI · Q2 FY2020
|
Q2 FY2020 |
|
MBI Q2 FY2020 transcript
|
|
IVR
Invesco Mortgage Capital Inc.
IVR · Q1 FY2020
|
Q1 FY2020 |
|
IVR Q1 FY2020 transcript
|
|
TCPC
BlackRock TCP Capital Corp.
TCPC · Q2 FY2020
|
Q2 FY2020 |
|
TCPC Q2 FY2020 transcript
|
|
HII
Huntington Ingalls Industries, Inc.
HII · Q2 FY2020
|
Q2 FY2020 |
|
HII Q2 FY2020 transcript
|
|
FTK
Flotek Industries Inc/Cn/
FTK · Q2 FY2020
|
Q2 FY2020 |
|
FTK Q2 FY2020 transcript
|
|
DDOG
Datadog, Inc.
DDOG · Q2 FY2020
|
Q2 FY2020 |
|
DDOG Q2 FY2020 transcript
|
|
MRAM
Everspin Technologies Inc.
MRAM · Q2 FY2020
|
Q2 FY2020 |
|
MRAM Q2 FY2020 transcript
|
|
BDX
Becton Dickinson & Co
BDX · Q3 FY2020
|
Q3 FY2020 |
|
BDX Q3 FY2020 transcript
|
|
KRP
Kimbell Royalty Partners, LP
KRP · Q2 FY2020
|
Q2 FY2020 |
|
KRP Q2 FY2020 transcript
|
|
IRWD
Ironwood Pharmaceuticals Inc
IRWD · Q2 FY2020
|
Q2 FY2020 |
|
IRWD Q2 FY2020 transcript
|
|
GNE
Genie Energy Ltd.
GNE · Q2 FY2020
|
Q2 FY2020 |
|
GNE Q2 FY2020 transcript
|
|
SNDX
Syndax Pharmaceuticals Inc
SNDX · Q2 FY2020
|
Q2 FY2020 |
|
SNDX Q2 FY2020 transcript
|
|
TGLS
Tecnoglass Holdings Inc.
TGLS · Q2 FY2020
|
Q2 FY2020 |
|
TGLS Q2 FY2020 transcript
|
|
WTI
W&T Offshore Inc
WTI · Q2 FY2020
|
Q2 FY2020 |
|
WTI Q2 FY2020 transcript
|
|
DGII
Digi International Inc
DGII · Q3 FY2020
|
Q3 FY2020 |
|
DGII Q3 FY2020 transcript
|
|
SPRO
Spero Therapeutics, Inc.
SPRO · Q2 FY2020
|
Q2 FY2020 |
|
SPRO Q2 FY2020 transcript
|
|
PRDO
PERDOCEO EDUCATION Corp
PRDO · Q2 FY2020
|
Q2 FY2020 |
|
PRDO Q2 FY2020 transcript
|
|
NAGE
Niagen Bioscience, Inc.
NAGE · Q2 FY2020
|
Q2 FY2020 |
|
NAGE Q2 FY2020 transcript
|
|
FSLR
First Solar, Inc.
FSLR · Q2 FY2020
|
Q2 FY2020 |
|
FSLR Q2 FY2020 transcript
|
|
NINE
Nine Energy Service, Inc.
NINE · Q2 FY2020
|
Q2 FY2020 |
|
NINE Q2 FY2020 transcript
|
|
NTLA
Intellia Therapeutics, Inc.
NTLA · Q2 FY2020
|
Q2 FY2020 |
|
NTLA Q2 FY2020 transcript
|